<img src="http://i.imgur.com/WeUeSj5.jpg" width='250px' alt='A patient with a cloudy, swollen cornea prior to cell injection. (Jeffrey L. Goldberg, M.D. — Stanford University School of click here now Medicine)’ align=’left’ /> Were cautiously optimistic. The Stanford team plans to expand the Learn More study in September to Phase 2 to measure how the vision of the patients improves. The effort has been endorsed by the American Academy of Ophthalmology, which says it supports innovative clinical Many countries outside the United States and Europe have a shortage of donor eye tissue, leaving millions of people unable to obtain a donor cornea. If this early research is found to be safe and effective, this technique may help some patients avoid corneal transplant, said Dr. Philip R. Rizzuto, clinical spokesman for the American Academy of Ophthalmology. If successful, the approach could also be used to replace other types of damaged eye cells, offering therapies for retinal and optic nerve diseases including glaucoma, the leading cause of irreversible blindness, he said. The approach is part of an expanding field of lab-grown cell therapies. Sheets of healthy skin are used to treat burns, chronic skin wounds and diseases like epidermolysis bullosa, which causes incurable blistering. And bioengineered cartilage is increasingly used to treat certain knee injuries.
For the original version including any supplementary images or video, visit http://www.santacruzsentinel.com/article/NE/20170416/NEWS/170419745